• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双功能催化介导4-氢过氧环磷酰胺和4-羟基环磷酰胺转化为磷酰胺芥和丙烯醛。

Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.

作者信息

Low J E, Borch R F, Sladek N E

出版信息

Cancer Res. 1982 Mar;42(3):830-7.

PMID:7059981
Abstract

The rates at which 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide are converted to phosphoramide mustard and acrolein were determined as a function of buffer composition, buffer concentration, and pH. Conversion of 4-hydroperoxycyclophosphamide to 4-hydroxycyclophosphamide in 0.5 M Tris buffer, pH 7.4, 37 degrees, was first-order (k = 0.016 min-1), but subsequent conversion of 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein under these conditions was negligible. Phosphoramide mustard and acrolein were readily generated from 4-hydroperoxycyclophosphamide or 4-hydroxycyclophosphamide when either of these agents was placed in phosphate buffer. Conversion of 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein was first-order with respect to 4-hydroxycyclophosphamide (k = 0.126 min-1 in 0.5 M phosphate buffer, pH 8, 37 degrees) as well as first-order with respect to phosphate serving as a catalyst. The rate-determining step in the reaction was pH dependent only insofar as the hydrogen ion concentration governed the relative amounts of monobasic and dibasic phosphate present. Pseudo-first-order rate constants were 0.045 M-1 min-1 for monobasic phosphate and 0.256 M-1 min-1 for dibasic phosphate. The role of phosphate in this reaction was as that of a bifunctional catalyst. The reaction was not subject to specific or general, acid or base, catalysis. Other bifunctional catalysts such as glucose-6-phosphate and bicarbonate also catalyzed the reaction, albeit less efficiently. Aldophosphamide apparently exists only transiently; its presence could not be established by 31P nuclear magnetic resonance spectroscopy. We conclude that, in the reaction sequence 4-hydroxycyclophosphamide leads to aldophosphamide leads to phosphoramide mustard + acrolein, the conversion of 4-hydroxycyclophosphamide to aldophosphamide is rate limiting and is subject to bifunctional catalysis; this reaction can proceed efficiently only in the presence of a bifunctional catalyst. Assuming that the oncotoxic specificity of cyclophosphamide resides with 4-hydroxycyclophosphamide and that its cytotoxic effect at therapeutic doses is largely mediated by phosphoramide mustard released within cells, these observations offer the possibility that the intracellular concentration of bifunctional catalysts, whether in the form of inorganic phosphates, organic phosphates, enzymes, or other species, serve as important determinants with regard to the oncotoxic potential and specificity of cyclophosphamide. Similarly, the concentration of bifunctional catalysis in the urine as well as the pH of the urine may be important with regard to the potential of cyclophosphamide to induce, via acrolein, hemorrhagic cystitis.

摘要

测定了4-氢过氧环磷酰胺和4-羟基环磷酰胺转化为磷酰胺芥和丙烯醛的速率,该速率是缓冲液组成、缓冲液浓度和pH值的函数。在pH 7.4、37℃的0.5M Tris缓冲液中,4-氢过氧环磷酰胺转化为4-羟基环磷酰胺是一级反应(k = 0.016 min⁻¹),但在这些条件下,随后4-羟基环磷酰胺转化为磷酰胺芥和丙烯醛的反应可忽略不计。当将这两种试剂中的任何一种置于磷酸盐缓冲液中时,磷酰胺芥和丙烯醛很容易从4-氢过氧环磷酰胺或4-羟基环磷酰胺中生成。4-羟基环磷酰胺转化为磷酰胺芥和丙烯醛对于4-羟基环磷酰胺是一级反应(在pH 8、37℃的0.5M磷酸盐缓冲液中k = 0.126 min⁻¹),对于作为催化剂的磷酸盐也是一级反应。反应中的限速步骤仅取决于pH值,因为氢离子浓度决定了存在的磷酸一氢盐和磷酸二氢盐的相对量。磷酸一氢盐的准一级速率常数为0.045 M⁻¹ min⁻¹,磷酸二氢盐的准一级速率常数为0.256 M⁻¹ min⁻¹。磷酸盐在该反应中的作用是双功能催化剂的作用。该反应不受特殊或一般的酸或碱催化。其他双功能催化剂,如6-磷酸葡萄糖和碳酸氢盐,也催化该反应,尽管效率较低。醛磷酰胺显然仅短暂存在;通过³¹P核磁共振光谱无法确定其存在。我们得出结论,在4-羟基环磷酰胺→醛磷酰胺→磷酰胺芥 + 丙烯醛的反应序列中,4-羟基环磷酰胺转化为醛磷酰胺是限速步骤,并且受到双功能催化;该反应仅在双功能催化剂存在下才能有效进行。假设环磷酰胺的肿瘤毒性特异性在于4-羟基环磷酰胺及其在治疗剂量下的细胞毒性作用很大程度上由细胞内释放的磷酰胺芥介导,这些观察结果提供了一种可能性,即双功能催化剂的细胞内浓度,无论是以无机磷酸盐、有机磷酸盐、酶或其他物质的形式,都是环磷酰胺肿瘤毒性潜力和特异性的重要决定因素。同样,尿液中双功能催化的浓度以及尿液的pH值对于环磷酰胺通过丙烯醛诱导出血性膀胱炎的可能性可能很重要。

相似文献

1
Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.双功能催化介导4-氢过氧环磷酰胺和4-羟基环磷酰胺转化为磷酰胺芥和丙烯醛。
Cancer Res. 1982 Mar;42(3):830-7.
2
Further studies on the conversion of 4-hydroxyoxazaphosphorines to reactive mustards and acrolein in inorganic buffers.关于4-羟基氮杂磷环在无机缓冲液中转化为活性芥子气和丙烯醛的进一步研究。
Cancer Res. 1983 Dec;43(12 Pt 1):5815-20.
3
Half-life of oxazaphosphorines in biological fluids.生物体液中氮杂磷三环类化合物的半衰期。
Drug Metab Dispos. 1984 Sep-Oct;12(5):553-9.
4
Accelerated decomposition of 4-hydroxycyclophosphamide by human serum albumin.人血清白蛋白对4-羟基环磷酰胺的加速分解作用。
Cancer Res. 1987 Mar 15;47(6):1505-8.
5
Influence of diuretics on urinary general base catalytic activity and cyclophosphamide-induced bladder toxicity.利尿剂对尿中总碱催化活性及环磷酰胺诱导的膀胱毒性的影响。
Cancer Treat Rep. 1982 Nov;66(11):1889-1900.
6
NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways.环磷酰胺中间代谢产物的核磁共振光谱研究。顺式和反式4-羟基环磷酰胺与醛磷酰胺相互转化以及醛磷酰胺在不可逆裂解和可逆共轭途径之间伴随分配的综合动力学分析。
J Med Chem. 1984 Apr;27(4):466-85. doi: 10.1021/jm00370a008.
7
Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.在为骨髓移植做准备而反复给予高剂量环磷酰胺的患者中,4-羟基环磷酰胺和磷酰胺氮芥的血浆浓度。
Cancer Treat Rep. 1984 Oct;68(10):1247-54.
8
In situ preparation and fate of cis-4-hydroxycyclophosphamide and aldophosphamide: 1H and 31P NMR evidence for equilibration of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and its hydrate in aqueous solution.顺式-4-羟基环磷酰胺和醛磷酰胺的原位制备及归宿:1H和31P NMR证据表明,在水溶液中,顺式和反式-4-羟基环磷酰胺与醛磷酰胺及其水合物存在平衡。
J Med Chem. 1984 Apr;27(4):490-4. doi: 10.1021/jm00370a010.
9
Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.环磷酰胺通过丙烯醛和磷酰胺氮芥的联合作用调节大鼠肝脏细胞色素P450 2C11和类固醇5α-还原酶活性及信使核糖核酸水平。
Cancer Res. 1993 Jun 1;53(11):2490-7.
10
Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.环磷酰胺的细胞毒性代谢产物磷酰胺芥和丙烯醛对小鼠肢体体外发育的影响。
Teratology. 1989 Jul;40(1):11-20. doi: 10.1002/tera.1420400103.

引用本文的文献

1
Therapeutic Targeting of DNA Replication Stress in Cancer.癌症中 DNA 复制应激的治疗靶向。
Genes (Basel). 2023 Jun 26;14(7):1346. doi: 10.3390/genes14071346.
2
Differential toxicity to murine small and large intestinal epithelium induced by oncology drugs.肿瘤药物对小鼠小肠和大肠上皮细胞的毒性差异。
Commun Biol. 2022 Jan 27;5(1):99. doi: 10.1038/s42003-022-03048-x.
3
Synthesis of cyclophosphamide metabolites by a peroxygenase from Marasmius rotula for toxicological studies on human cancer cells.通过来自小孢拟盘多毛孢的过氧合酶合成环磷酰胺代谢物用于对人类癌细胞的毒理学研究。
AMB Express. 2020 Jul 18;10(1):128. doi: 10.1186/s13568-020-01064-w.
4
Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system.研究肝代谢对多器官人源芯片系统中靶外心脏毒性的影响。
Biomaterials. 2018 Nov;182:176-190. doi: 10.1016/j.biomaterials.2018.07.062. Epub 2018 Aug 4.
5
Glutathione S-transferase P protects against cyclophosphamide-induced cardiotoxicity in mice.谷胱甘肽S-转移酶P可保护小鼠免受环磷酰胺诱导的心脏毒性。
Toxicol Appl Pharmacol. 2015 Jun 1;285(2):136-48. doi: 10.1016/j.taap.2015.03.029. Epub 2015 Apr 10.
6
Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide.验证一种新方法来定量检测接受环磷酰胺治疗的个体中磷酰胺氮芥的形成。
Cancer Chemother Pharmacol. 2014 Sep;74(3):549-58. doi: 10.1007/s00280-014-2524-7. Epub 2014 Jul 23.
7
Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity.谷胱甘肽S-转移酶P基因敲除小鼠对环磷酰胺诱导的膀胱毒性敏感性增加。
J Pharmacol Exp Ther. 2009 Nov;331(2):456-69. doi: 10.1124/jpet.109.156513. Epub 2009 Aug 20.
8
A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients.一种基于机制的乳腺癌患者环磷酰胺自身诱导的药代动力学-酶模型。
Br J Clin Pharmacol. 1999 Nov;48(5):669-77. doi: 10.1046/j.1365-2125.1999.00090.x.
9
Dithio-bis-mercaptoethanesulphonate (DIMESNA) does not prevent cellular damage by metabolites of ifosfamide and cyclophosphamide in LLC-PK1 cells.二硫代双巯基乙烷磺酸盐(美司钠)不能预防异环磷酰胺和环磷酰胺的代谢产物对LLC-PK1细胞造成的细胞损伤。
Pediatr Nephrol. 1994 Aug;8(4):458-65. doi: 10.1007/BF00856531.
10
Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture.异环磷酰胺、环磷酰胺及其代谢产物对培养的肾小管细胞的毒性作用。
Pediatr Nephrol. 1994 Apr;8(2):157-63. doi: 10.1007/BF00865466.